Quantcast

Latest AMD Stories

2014-08-14 12:27:38

Over Three-Quarters of Physicians View Ophthotech's Fovista as an Emerging Therapy with High Potential Value for Wet AMD, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug. 14, 2014 /PRNewswire/ -- Decision Resources Group finds that physician-reported patient shares for Regeneron's Eylea, as well as the other major anti-vascular endothelial growth factor (VEGF) agents Genentech/Roche's Avastin and Genentech/Roche's Lucentis, have now stabilized among wet age-related...

2014-07-28 08:27:34

Surpasses Rival Offerings with Support for 25x More Games, Extends Experience to Include Seamless Uploading, Sharing and Community MOUNTAIN VIEW, Calif., July 28, 2014 /PRNewswire/ -- Raptr, a leading online service for PC gamers, today introduced a major update that elevates gameplay video capture to a new level. Foremost among the advancements is the ability to record or stream gameplay video with virtually no degradation of system performance thanks to hardware encoding support...

2014-07-09 23:07:16

Global Graphics Add-in Board Market 2014-2018, a new research report added to Sandlerresearch.org store. Dallas, Texas (PRWEB) July 09, 2014 Vendors such as AMD and Nvidia have already invested a considerable amount of time and money in R&D to expand their product portfolio, provide better functionality, and meet end-user requirements. The increase in R&D investments has enabled vendors to capture a significant market share and gain a competitive edge over other market vendors....

2014-07-09 08:28:58

First clinical trial of integrated approach underlines need for inclusion of behavior activation therapy in low vision rehabilitation SAN FRANCISCO, July 9, 2014 /PRNewswire-USNewswire/ -- The first clinical trial to examine integrated low vision and mental health treatment has shown that the approach can reduce the incidence of depression by half among people with low vision due to age-related macular degeneration (AMD). The results of the study were published online today in Ophthalmology,...

2014-07-01 23:01:42

Diopsys® NOVA-ERG provides a way to discriminate between AMD and healthy eyes. Pine Brook, NJ (PRWEB) July 01, 2014 In a controlled clinical study, a team of researchers from New York Eye and Ear Infirmary concluded that test data from the Diopsys® NOVA-ERG vision test provides a way to discriminate both dry and wet Age-Related Macular Degeneration (AMD) eyes from healthy eyes. The study results published in a poster titled 'Steady State Pattern Electroretinography (ssPERG)...

2014-06-19 08:28:14

SOPHIA ANTIPOLIS, France, and SAN DIEGO, June 19, 2014 /PRNewswire/ -- Nicox S.A. (NYSE Euronext Paris: COX), the international ophthalmic company, and Sequenom, Inc. (NASDAQ:SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that Nicox's subsidiary, Nicox Inc. is launching expanded access to Sequenom Laboratories' RetnaGene(TM) portfolio of laboratory-developed genetic tests in the United States (U.S.). The RetnaGene portfolio includes...

2014-06-12 23:09:39

Ophthalmologist Michael Tracy, MD of Carlsbad Eye Care describes new findings on potential eye dangers. San Diego, CA (PRWEB) June 12, 2014 A recent study by the American Academy of Ophthalmology has found a link between age-related macular degeneration (AMD) and medications for managing high blood pressure. According to the study, vasodilators are associated with a nearly 75% greater risk of developing AMD or other vision-threatening diseases. Carlsbad ophthalmologist Dr. Michael Tracy...

2014-06-11 04:21:59

TARRYTOWN, N.Y., June 11, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare today announced that Bayer HealthCare has submitted an application to the European Medicines Agency (EMA) seeking marketing authorization in the European Union (EU) for EYLEA(®) (aflibercept) Injection for the treatment of macular edema following branch retinal vein occlusion (BRVO). The EMA submission is based on the positive Phase 3 VIBRANT trial, a double-masked,...

2014-06-05 12:30:20

LONDON, June 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Marketshttp://www.reportbuyer.com/pharma_healthcare/medical_devices/ophthalmic_devices_diagnostics_surgical_equipment_global_markets.html INTRODUCTIONSTUDY GOALS AND OBJECTIVESThis BCC report, Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets, provides a comprehensive description of conditions and diseases that...

2014-05-28 16:24:35

Major population study finds vasodilators may raise likelihood of age-related macular degeneration SAN FRANCISCO, May 28, 2014 /PRNewswire-USNewswire/ -- There may be a connection between taking vasodilators and developing early-stage age-related macular degeneration (AMD), the leading cause of vision loss and blindness among Americans who are age 65 and older,[1] according to a study published online in Ophthalmology, the journal of the American Academy of Ophthalmology....


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related